Close×

Result Group, a leading supplier of innovative packaging equipment and materials, will be holding a virtual site tour of its operations, and those of its partners Herma and Hanes, on 5 August, under the auspices of the AIP.

Among its advanced solutions is the Herma InNo Liner – a PIDA and WorldStar Award-winning labelling technology, which eliminates landfill waste by removing silicone, reducing disposal costs, lowering transport volume, and boosting material efficiency.

Hanes Australasia – owner of brands like Bonds, Sheridan, Champion, and Bras N Things – is an early adopter of this system in order to meet its 2025 sustainability goals. Operating 24/7, the system provides labelling with no release liner, no silicone content, and zero waste disposal.

AIP members are invited to join Result Group on an insightful journey that will start in the company’s Demo Room, followed by a trip to Herma’s headquarters in Germany, then returning to Australia to check out Hanes Australasia’s operations.

Attendees can experience first-hand how the innovative Herma InNo Liner system operates in real-time and uncover the substantial sustainability and efficiency benefits it brings to the business.

After the tour, there will be a Q&A session with Sebastian Siccita, group general manager – Logistics at Hanes Australasia; Michael Dossor, general manager at Result Group; and Paul Rushton, technical operations manager at Result Group.

To book your spot for the virtual tour, click here.

Food & Drink Business

New CEO for Bulla

Family-owned manufacturer, Bulla Dairy Foods, has appointed Peter Hall as CEO. Hall joins in September, returning to Australia after more than 25 years running food and beverage businesses across North America, Europe, Latin America and the Caribbean.

Treasury Wine Estates has reported a statutory net loss of $1,078.7 million for FY26, with $1.31 billion in post-tax material items from its US write-downs drowning out an operating result that landed ahead of guidance.

Seedlab Australia says FMCG brands need to be more thoughtful about whether protein genuinely adds value, or whether it risks becoming the next overused health claim.